Written questions by Collins.

Whether his Department plans to train carers in using musical techniques to support people living with dementia.

We are committed to a professional, well supported social care workforce. Under the Health and Social Care Act 2008, providers must provide enough suitably qualified, competent, skilled, and experienced staff to meet the needs of the people using the service. Staff must receive the support, training, professional development, supervision, and appraisals that are necessary for them to carry out their role.The Department currently funds research on the use of musical techniques for people living with dementia via the National Institute for Health and Care Research. This includes a major study investigating how music therapy can reduce patient distress and physical assaults on National Health Service inpatient wards for people with dementia. The study is called MELODIC and will create a programme of music therapy which will be piloted in two NHS mental health wards at the Cambridgeshire and Peterborough NHS Foundation Trust.

Whether he plans to include policies on supporting people with dementia in the 10-year health plan for the NHS.

We have committed to develop a 10 Year Plan to deliver a National Health Service fit for the future. We will carefully be considering policies, including those that impact people with dementia, with input from the public, patients, health staff, and our partners, as we develop the plan. In February, I hosted a roundtable discussion where partners considered how dementia, ageing well, and digital inclusion could be reflected in the 10 Year Plan. I would also encourage people to take part in our public engagement exercise, which is helping us to fully understand what in the NHS is not working as well as it should, and what the potential solutions are. Further information is available at the following link: https://change.nhs.uk/en-GB/

Whether his Department has had discussions with NHS England on the potential merits of promoting the return and reissue of reusable NHS medical equipment.

The Department published the Design for Life Roadmap in October 2024, which sets out the Government's ambition to transition away from all avoidable single-use medical technology products by 2045. One of the key mechanisms for doing this, as outlined in the roadmap, is maximising reuse in the National Health Service. The roadmap includes a suite of 30 actions to deliver the 2045 vision, which NHS England were closely involved in creating. We are now working together to deliver these actions, including through joint working groups.

What steps his Department is taking to tackle regional variations in early diagnosis of ovarian cancer.

We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. NHS Planning Guidance, issued on 30 January 2025, set stretching targets for cancer. By March 2026, approximately 100,000 more people every year will be told whether they have cancer or not within 28 days, and 17,000 more people will begin treatment within two months of a referral.Meeting these targets for cancer will ensure that no patient waits longer than they should for diagnosis or treatment, and we have started by delivering an extra 40,000 operations, scans, and appointments each week, to support faster diagnosis and access to treatment.Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.We do not currently have access to information on how many people have been diagnosed with ovarian cancer through the non-specific symptoms pathway.

How many people have been diagnosed with ovarian cancer through the non-specific symptoms pathway.

We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. NHS Planning Guidance, issued on 30 January 2025, set stretching targets for cancer. By March 2026, approximately 100,000 more people every year will be told whether they have cancer or not within 28 days, and 17,000 more people will begin treatment within two months of a referral.Meeting these targets for cancer will ensure that no patient waits longer than they should for diagnosis or treatment, and we have started by delivering an extra 40,000 operations, scans, and appointments each week, to support faster diagnosis and access to treatment.Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.We do not currently have access to information on how many people have been diagnosed with ovarian cancer through the non-specific symptoms pathway.

What steps he is taking to improve the accessibility of dental care during the maternity exemption period.

We are aware of the challenges faced in accessing a dentist and we want to make sure that everyone who needs a National Health Service dentist can get one, including pregnant women and new mothers. The Government plans to tackle the challenges for patients trying to access NHS dental care with a rescue plan to provide 700,000 more urgent dental appointments and recruit new dentists to areas that need them most. The responsibility for commissioning primary care services, including NHS dentistry, to meet the needs of the local population has been delegated to Integrated Care Boards across England. For Harpenden and Berkhamsted constituency, this is the Hertfordshire and West Essex ICB.

What assessment he has made of the potential impact of AI integration in health on productivity in (a) radiology and (b) oncology.

Artificial intelligence (AI) technologies have huge potential in improving productivity across the National Health Service by supporting clinicians with faster and more accurate diagnosis, enhancing clinical decision-making about treatment plans, and reducing the administrative burden faced by healthcare staff. The Department and NHS England are developing guidance for the responsible use of these tools and how they can be rolled out to make the day-to-day operations of the NHS more productive. To further support staff productivity in radiology and oncology, the Department is focusing the £21 million AI Diagnostic Fund on the integration of AI technologies in key, high-demand areas such as radiology, particularly for chest X-Rays and chest computed tomography scans, to enable faster diagnosis and treatment of lung cancer in over half of acute trusts in England. The Department is also working closely with regulators to assess the impact of AI integration on healthcare staff productivity and identify new measures for providing assurance, with the launch of AI Airlock. A Medicines and Healthcare products Regulation Agency-led initiative, supported by the Department, designed to create a controlled testing environment where developers can rigorously validate AI tools in real-world clinical settings before full-scale deployment, ensuring they meet NHS standards for safety, efficacy, value for money, and integration into existing healthcare workflows, including productivity. This initiative provides valuable feedback for developers to refine their products to ensure assessments are carried out on the impact to staff before eventually being deployed into the NHS.In addition, the National Institute for Health and Care Excellence (NICE), sponsored by the Department, evaluates new health technologies for NHS use, considering clinical effectiveness, value for money, and impacts on staff. As part of this, the NICE conducts Early Value Assessments (EVA) for developers, reviewing their AI tools before they are deployed. For the NHS, EVAs aim to give the NHS a clear signal about which innovations work, offer good value for money, and meet system need, including productivity gains for staff.The NHS also partnered with the Royal College of Radiologists to deliver the first Global AI Conference on 3 and 4 February 2025. AI projects across radiology, oncology, and other clinical specialties were discussed at the conference, including how AI could support radiologists and oncologists to be more productive and offer a high standard of treatment to the public. The 10-Year Health Plan is committed to reviewing how the NHS should focus its resources to ensure it maximises the impact of data and technology, including how we can make life easier and more productive for those who work in the NHS. AI will play an important role to achieve this long-term ambition by building and delivering AI capabilities, which will allow clinicians, such as radiologists and oncologists, to focus more on direct patient care and staff to spend more time on high value, high impact tasks.

Whether his Department plans to ensure that NHS trusts have access to similar AI technologies by having approved models in line with the provision of medical equipment.

The Department is working to accelerate the safe, ethical, and effective use of artificial intelligence (AI) across the whole healthcare system. The Department has already provided £113 million, through the NHS AI Health and Care Awards, to 86 AI technologies, which have been used in 40% of National Health Service acute trusts in England, and hundreds of Primary Care Networks across the United Kingdom. This funding has helped to generate the evidence needed to deploy effective AI tools across the NHS.The NHS operates within a comprehensive regulatory framework for AI, underpinned by rigorous standards established by bodies including the Medicines and Healthcare products Regulatory Agency, National Institute for Health and Care Excellence (NICE), the Health Research Authority, and the Care Quality Commission. These agencies ensure that any AI technologies that are made available to the NHS are safe, effective, and ethical to use.Additionally, the NICE, sponsored by the Department, conducts Early Value Assessments (EVA) which evaluate new health technologies for NHS use, considering clinical effectiveness and value for money. EVAs aim to give the NHS recommendations and highlight the accessibility of AI technologies, including which innovations work, offer good value for money, and meet system need.For trusts procuring technology there is a standardised procurement route available through specialised procurement frameworks. These frameworks offer NHS trusts access to a list of suppliers who have met a set of standards to be invited to join the framework.

Whether his Department plans to allocate funding for (a) secure data environments for data validation and (b) other infrastructure required for AI implementation in the NHS.

Secure access to data to accelerate research and development is an important lever in delivering the Government’s health and growth missions. Access to National Health Service data across England has been supported by investments in digital infrastructure between 2022 and 2025 by the Data for Research and Development programme’s implementation of Secure Data Environment (SDEs) at a national and regional level. The programme’s investment into SDEs supports the full spectrum of data-driven research, including artificial intelligence (AI) development. The budget for the programme for 2025/6 is currently being finalised alongside other priority NHS transformation programmes. Funding plans beyond 2026 will be agreed as part of the Spending Review. Improved digital and data infrastructure, such as Electronic Patient Records, are essential foundations for digital transformation, such as AI. The NHS has one of the largest and most comprehensive longitudinal patient datasets in the world, making it an attractive location for the development and testing of AI. The centralisation of the healthcare system streamlines data accessibility, integration, and standardisation, all of which benefit the development and deployment of AI. Part of our work will be to create the right environment for the United Kingdom to safely deploy AI at scale, and to attract AI researchers and companies that both develop for, and sell to, UK health and care.

What assessment he has made of levels of workforce requirements needed for AI adoption and innovation in (a) radiology and (b) clinical oncology.

As part of the 10-Year Health Plan, we are reviewing how the National Health Service should focus its resources to ensure it maximises the impact of data and technology. This includes how we can make life easier and more productive for those who work in the NHS, and how we can use data more effectively to plan, manage, and deliver services. Artificial intelligence (AI) will play an important role in achieving this long-term ambition by building and delivering AI capabilities which will allow clinicians to focus more on direct patient care, and will allow staff to spend more time on high value, high impact tasks.The Government recognises that a cancer-specific approach is needed to meet the challenges in cancer care, and to improve outcomes for people living with cancer. Following publication of the 10-Year Health Plan, we will publish a new National Cancer Plan, which will include further details on how we will improve outcomes for cancer patients.The Department, with NHS England, has convened an expert group to identify advanced technology that can be used most effectively in the NHS, building on the findings of the Topol Review. Alongside this work, the Department and NHS England will continue to work with professions to embrace technological innovations, such as AI.

What steps his Department is taking to monitor quality control of new AI products used in the NHS to ensure (a) value for money and (b) return on investment.

Against a backdrop of increasing demand for National Health Services and significant workforce pressures, artificial intelligence (AI) presents significant opportunities for improving the delivery of care and outcomes for patients, while also saving money and staff time.Continuous monitoring after deployment is essential to ensure rigorous quality control of new AI products, value for money, and return on investment. The Department is working closely with regulators to identify new measures for providing assurance.The Department has launched regulatory projects, such as the AI Airlock, to support this aim. AI Airlock is a Medicines and Healthcare products Regulation Agency-led initiative designed to create a controlled testing environment where developers can rigorously validate AI tools in real-world clinical settings before full-scale deployment, ensuring they meet NHS standards for safety, efficacy, value for money, and integration into existing healthcare workflows. This initiative provides valuable feedback for developers to refine their products to ensure a return on investment, when eventually deployed into the NHS.In addition, the National Institute for Health and Care Excellence (NICE), sponsored by the Department, evaluates new health technologies for NHS use, considering clinical effectiveness and value for money. As part of this, the NICE conducts Early Value Assessments (EVA) for developers, reviewing their AI tools, including their value for money and return on investment, before they are deployed. For the NHS, EVAs aim to give the NHS a clear signal about which innovations work, offer good value for money, and meet system need.In the United Kingdom, the vast majority of AI products being used in health and care are regulated as medical technologies. This means they are subject to stringent requirements, primarily set out in The Medical Devices Regulations 2002, and robust monitoring by the Medicines and Healthcare products Regulation Agency.The responsibility for spending decisions rests with individual NHS trusts. As public bodies, NHS trusts should maintain the highest standards of rigour, value for money, and propriety in the use of public funding. All spending must contribute to organisational objectives and support the delivery of high-quality patient care.

If his Department will establish a standard process for the implementation of AI applications in the NHS.

The implementation of artificial intelligence (AI) in the National Health Service is still at a relatively early stage. To address this, the Department is carrying out work to assess the barriers of effective adoption and improve the way AI tools are implemented across the NHS.The Department is supporting the NHS to adopt the latest innovations in digital technology, such as AI. £2 billion has been allocated to digitise the NHS and £113 million has been provided to accelerate the evaluation and deployment of the most promising AI technologies.Additionally, the Department has supported the launch of regulatory projects to begin to create a standardized process for AI implementation, such as with the AI and Digital Regulation Service (AIDRS) and the AI Airlock.The AIDRS, in partnership with healthcare regulators, gives innovators and health and care providers a one-stop-shop for support, information, and guidance on the regulatory and evaluation pathways that need to be followed before an AI tool can be safely implemented across the NHS. The AI Airlock is a Medicines and Healthcare products Regulatory Agency-led initiative, supported by the NHS AI Lab, designed to create a controlled testing environment where developers can rigorously validate AI tools in real-world clinical settings before full-scale deployment, ensuring they meet NHS standards for safety, efficacy, and integration into existing healthcare workflows.Following the announcement of the Government’s AI Opportunities Action Plan, the Department of Health and Social Care and NHS England have been working with Prime Minister's Office to develop specific proposals of how they will promote the implementation of AI. This includes using a Scan, Pilot, Scale model approach to investing and supporting AI development, to ensure that useful AI tools are quickly identified, tested and, where successful, implemented to improve the lives of United Kingdom citizens.

What steps he is taking to ensure public engagement with AI implementation in the NHS.

As part of Government’s five long-term missions, the Department has launched a 10-Year Health Plan to reform the National Health Service and make it fit for the future. The plan will set out an agenda to deliver on the three big shifts needed, to move healthcare from hospital to the community, sickness to prevention, and analogue to digital.In addition to launching the online platform, change.NHS.UK, there have been many events across England, which included people and staff from different backgrounds and experiences. In-depth deliberations with the public will consider their priorities and expectations on the three shifts, including their views on the use of artificial intelligence (AI). Further information on the change.NHS.UK website is available at the following link:www.change.NHS.ukThe Department also engages with Understanding Patient Data (UPD) to ensure that we consider the patient in our policy and strategic thinking. UPD provides objective information about how patient data is used and brings the views of patients and the public to us, to ensure data is being managed and used in ways that are worthy of public trust. Further information on UPD is available at the following link:https://understandingpatientdata.org.uk/As part of its work on AI, the NHS AI Lab and Sciencewise, within UK Research and Innovation, held a public dialogue on how the public believes decisions should be made about access to their personal health data for AI purposes. The AI Lab conducted a discovery exercise to design approaches based on insights from the public, which is now informing broader data stewardship initiatives, for example, as part of the Secure Data Environments.In addition, NHS England has recruited patient representatives, Patient and Public Voice Partners, for the AI Advisory Committee on Responsible AI Adoption, to ensure that the committee considers the views of service users, patients, and the public in its advice to the system on the development and delivery of AI.

Whether the (a) 10 Year Health Plan and (b) Long-Term Workforce Plan will link to the AI Opportunities Plan.

As part of the 10-Year Health Plan we are reviewing how the National Health Service should focus its resources to ensure that it maximises the impact of data and technology. This includes how we can make life easier and more productive for those who work in the NHS, and how we can use data more effectively to plan, manage and deliver services. This will also be reflected in the refreshed Long-Term Workforce Plan.Artificial intelligence (AI) will play an important role in achieving this long-term ambition, allowing clinicians to focus more on direct patient care and allowing staff to spend more time on high value, high impact tasks. The AI Opportunities Action Plan sets out a desire to shape the AI revolution on principles of shared economic prosperity, improved public services, and increased personal opportunities.

What funding will be made available to NHS trusts to integrate AI technology.

The NHS AI Lab has already provided £113 million, through the NHS AI Health and Care Awards, to 86 artificial intelligence (AI) technologies, which have been used in 40% of National Health Service acute trusts in England and hundreds of Primary Care Networks across the United Kingdom. The awards have helped accelerate the testing and evaluation of AI technologies and developed an evidence base to support the commissioning of technologies that are clinically safe and cost effective. Many of these AI technologies are being tested and evaluated in NHS England to aid clinical decision-making, healthcare diagnostics, and imaging. For example, the Department is focusing the £21 million AI Diagnostic Fund on the deployment of technologies in key, high-demand areas such as chest x-ray and chest computed tomography scans, to enable faster diagnosis and treatment of lung cancer in over half of acute trusts in England.In addition, the National Institute for Health and Care Research, sponsored by the Department, has funded an £11 million trial, which will use artificial intelligence for breast cancer screening. The trial will be launched across the country and showcases our commitment to embracing innovative technologies in healthcare.The Department is also supporting the NHS to adopt the latest innovations in digital technology, such as artificial intelligence, with £2 billion having been allocated to digitise the NHS. All future spending commitments beyond 2025/26 will be dependent on the outcome of Phase 2 of the Spending Review process, which will conclude and be published in late spring of 2025.

Whether he plans to issue guidance to ensure that people diagnosed with ADHD through private healthcare can access NHS prescriptions without additional assessment.

General practitioners (GPs) are independent contractors that provide services within the National Health Service. The General Medical Council (GMC) has issued guidance on “Good practice in proposing, prescribing, providing and managing medicines and devices content”. This includes guidance on shared care arrangements between a specialist service and the patient’s GP to help GPs decide whether to accept shared care responsibilities, which is available at the following link:https://www.gmc-uk.org/professional-standards/the-professional-standards/good-practice-in-prescribing-and-managing-medicines-and-devices/shared-careNHS clinicians therefore need to be content that any prescriptions, or referrals for treatment, are clinically appropriate. If a shared care arrangement cannot be put in place after the treatment has been initiated, the responsibility for continued prescribing falls upon the specialist clinician; this applies to both NHS and private medical care.We are supporting a cross-sector taskforce that NHS England has established to look at attention deficit hyperactivity disorder (ADHD) service provision and support across sectors, and their impact on patient experience. The taskforce is bringing together expertise from across a broad range of sectors, including the NHS, education, and justice, to better understand the challenges affecting people with ADHD, including timely access to services and support.

Whether he has made a recent assessment of the potential merits of extending the Start for Life programme to (a) Harpenden and Berkhamsted constituency and (b) other local authorities that do not receive funding through the programme.

The Prime Minister’s Plan for Change outlined that there will be investment to continue to build up the Family Hubs and Start for Life programme. In 2025/26, this investment will fund the 75 local authorities in England with high levels of deprivation that are part of the existing programme.Due to the challenging fiscal context, we have had to make difficult decisions for 2025/26, and only those areas currently in the scheme will receive Start for Life funding. We will continue to evaluate the programme and assess evidence to support wider rollout in future financial years.

Whether he plans to extend free NHS dental repairs to teeth damaged by seizures from epilepsy.

Free National Health Service dental care is available to people who meet the following criteria: under 18 years old, or under 19 years old and in full-time education; pregnant or have had a baby in the previous 12 months; being treated in an NHS hospital and the treatment is carried out by the hospital dentist, keeping in mind that patients may have to pay for any dentures or bridges; receiving low-income benefits, or under 20 years old and a dependant of someone receiving low-income benefits.Support is also available through the NHS Low Income Scheme for those patients who are not eligible for exemption or full remission of dental patient charges. More information is available at the following link:https://www.nhs.uk/nhs-services/dentists/who-is-entitled-to-free-nhs-dental-treatment-in-england/Community dental services provide specialised dental services to people with additional needs and are available in a variety of places to ensure everyone can have access to dental care. These include hospitals, specialists’ health centres and mobile clinics, as well as home visits or visits in nursing and care homes. These services may be available to people with epilepsy, depending on their needs.

What assessment his Department has made of the adequacy of the availability of activity blades for amputees over 18.

Prosthetics services are overseen by NHS England. They do not commission activity blades for amputees over 18 years old, and have no current plans change this.Currently, NHS England provides adult amputees primary prostheses, activity limbs, and adaptations for non-competitive sports, but does not extend this support to high-end sports-specific prosthetics necessary for competitive-level participation.

Whether his Department plans to introduce measures to improve patient safety in non-surgical cosmetic procedures.

The Government is committed to taking action to address concerns about the safety of the non-surgical cosmetics sector, and will set out the details of its approach at the earliest opportunity.